Home › Tricuspid Valve Insufficiency › NCT06033274
Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment
Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment: the TRIPLACE Registry
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients undergoing Transcatheter Tricuspid Valve Replacement * Native Tricuspid Valve disease * Orthotopic Tricuspid Valve Implantation Exclusion Criteria: * Age under 18 years
About the study
The field of transcatheter tricuspid valve replacement (TTVR) is rapidly emerging and data on this topic are scarce. Particularly, little is known about which patients are at greatest risk of procedural complications, such as the timing and onset of conduction disturbances necessitating permanent pacemaker implantation, and how such patients are managed. On this background, the TRIPLACE Registry - an investigator-initiated global multicenter registry - is aimed at better understanding the safety and efficacy of orthotopic TTVR.
What is being tested
- Transcatheter Tricuspid Valve Replacement (device)
Sponsor: Montefiore Medical Center · Participants: 800 · Started: Oct 5, 2023
Contact the study team
- Andrea Scotti, MD · Phone: 7189043388
- Rishi Puri, MD · Phone: (216) 444-2273
Official record on ClinicalTrials.gov — NCT06033274
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.